HURA
TuHURA Biosciences Inc.

15,579
Mkt Cap
$108.69M
Volume
381,129.00
52W High
$4.44
52W Low
$0.41
PE Ratio
-2.57
HURA Fundamentals
Price
$1.62
Prev Close
$1.79
Open
$1.84
50D MA
$1.35
Beta
0.49
Avg. Volume
773,441.18
EPS (Annual)
-$0.6272
P/B
4.65
Rev/Employee
$0.00
$33.63
Loading...
Loading...
News
all
press releases
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and...
PR Newswire·20h ago
News Placeholder
More News
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Releases Earnings Results, Beats Expectations By $0.02 EPS
TuHURA Biosciences (NASDAQ:HURA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus...
MarketBeat·1d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of TuHURA Biosciences from a "sell" rating to a "hold" rating in a research report on Monday...
MarketBeat·3d ago
News Placeholder
Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers Craig Tendler, M.D., JNJ's Former...
PR Newswire·10d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen downgraded shares of TuHURA Biosciences from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·11d ago
News Placeholder
TuHURA Biosciences (HURA) Expected to Release Quarterly Earnings on Thursday
TuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Thursday, March 26. (View Earnings Report at...
MarketBeat·14d ago
News Placeholder
TuHURA Biosciences (NASDAQ:HURA) Trading Down 3.1% - Here's Why
TuHURA Biosciences (NASDAQ:HURA) Stock Price Down 3.1% - What's Next...
MarketBeat·19d ago
News Placeholder
Wall Street Zen Upgrades TuHURA Biosciences (NASDAQ:HURA) to "Hold"
Wall Street Zen upgraded TuHURA Biosciences from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·19d ago
News Placeholder
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire TAMPA, Fla., Feb. 27, 2026...
PR Newswire·1mo ago
News Placeholder
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences
TuHURA Biosciences Announces Participation in Upcoming Investor Conferences TuHURA Biosciences Announces Participation in Upcoming Investor Conferences PR Newswire TAMPA, Fla., Feb. 24, 2026 TAMPA...
PR Newswire·1mo ago
<
1
2
...
>

Latest HURA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.